Delivery Order SPE2DB22D2206-SPE2DB24FDS88
Award Date
10/16/23
Potential Completion Date
10/17/23
Potential Value
$46K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,657.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, with a performance period through May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Lupron Depot-Ped 30 mg 3-month kits to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $71,890.96 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award, valued at $19,109.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LUPRON DEPOT-PED 45 MG 6MO KITS, a pharmaceutical product used in pediatric healthcare. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $38,110.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, valued at $15,298.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen, with the DLA Troop Support Medical....
This federal contract award is for the delivery of Lupron Depot-Ped 30 mg 3-month kits, a pharmaceutical product used to treat certain medical conditions in pediatric patients. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $6,131.71 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,235.38 firm fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC with the DLA Troop...
This federal contract award, valued at $7,145.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of February 4, 2025 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award is for the delivery of Lupron Depot-Ped 7.5 mg kits to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The award, valued at $1,731.18, was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This is a delivery order contract with a firm fixed price, and the ultimate completion date is December 22, 2023. The contract was awarded on December 21, 2023, and there was no...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,486.64, is for the delivery of LUPRON DEPOT-PED 30 MG 3MO KITS, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC...